NorthCrest Asset Manangement’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,700
| Closed | -$87.6K | – | 576 |
|
|
2024
Q3 | $87.6K | Hold |
11,700
| – | – | ﹤0.01% | 543 |
|
|
2024
Q2 | $104K | Hold |
11,700
| – | – | ﹤0.01% | 506 |
|
|
2024
Q1 | $119K | Sell |
11,700
-200
| -2% | -$2.03K | ﹤0.01% | 496 |
|
|
2023
Q4 | $120K | Hold |
11,900
| – | – | ﹤0.01% | 504 |
|
|
2023
Q3 | $112K | Hold |
11,900
| – | – | ﹤0.01% | 492 |
|
|
2023
Q2 | $292K | Sell |
11,900
-400
| -3% | -$9.81K | 0.01% | 447 |
|
|
2023
Q1 | $286K | Buy |
12,300
+900
| +8% | +$20.9K | 0.01% | 445 |
|
|
2022
Q4 | $289K | Buy |
11,400
+800
| +8% | +$20.3K | 0.02% | 357 |
|
|
2022
Q3 | $204K | Hold |
10,600
| – | – | 0.01% | 419 |
|
|
2022
Q2 | $270K | Hold |
10,600
| – | – | 0.01% | 388 |
|
|
2022
Q1 | $273K | Buy |
10,600
+200
| +2% | +$5.15K | 0.01% | 369 |
|
|
2021
Q4 | $435K | Buy |
+10,400
| New | +$435K | 0.02% | 327 |
|